Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?

By Jones Hendrée E.   Kaltenbach Karol   Heil Sarah H.   Stine Susan M.   Coyle Mara G.   Arria Amelia M.   O’Grady Kevin E.   Selby Peter   Martin Peter R.   Jansson Lauren   Fischer Gabriele  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Iss. 7, 2012-07 ,pp. : 1197-1201

Informa Healthcare

Access to resources Recommend Favorite

Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates

By Jansson Lauren M.   Dipietro Janet A.   Elko Andrea   Velez Martha  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 20, Iss. 9, 2007-01 ,pp. : 677-685

Informa Healthcare

Access to resources Recommend Favorite

Treatment of menorrhagia with the levonorgestrel intrauterine system: can we learn from our failures?

By Ikomi A.   Mansell Elizabeth   Spence-Jones C.   Singer A.  

Journal of Obstetrics & Gynaecology, Vol. 20, Iss. 6, 2000-11 ,pp. : 630-631

Informa Healthcare

Access to resources Recommend Favorite

Does the intrauterine growth-restricted fetus benefit from antenatal glucocorticoids?

By Orgeig Sandra   Morrison Janna L  

Expert Review of Obstretrics and Gynecology, Vol. 5, Iss. 2, 2010-03 ,pp. : 149-152

Informa Healthcare

Access to resources Recommend Favorite

Intrauterine therapy in a fetus with congenital dyserythropoietic anaemia type I

By Lin S. M.   Chen M.   Ma E. S. K.   Lam Y. H.   Wong K. Y.   Tang M. H. Y.  

Journal of Obstetrics & Gynaecology, Vol. 34, Iss. 4, 2014-05 ,pp. : 352-353

Informa Healthcare

Access to resources Recommend Favorite